{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:15:03Z","timestamp":1792664103679,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P50 NS058830"],"award-info":[{"award-number":["P50 NS058830"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.expneurol.2020.113327","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T11:36:17Z","timestamp":1588678577000},"page":"113327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats"],"prefix":"10.1016","volume":"330","author":[{"given":"Kathy","family":"Steece-Collier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack W.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Stancati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Winn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson","family":"Cole-Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhyomi","family":"Sellnow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natosha M.","family":"Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo A.","family":"Nillni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryl E.","family":"Sortwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredric P.","family":"Manfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4623-1085","authenticated-orcid":false,"given":"Christopher","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 4","key":"10.1016\/j.expneurol.2020.113327_bb0005","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/awr028","article-title":"Glutamate NMDA receptor dysregulation in Parkinson\u2019s disease with dyskinesias","volume":"134","author":"Ahmed","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2020.113327_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1423-0127-21-27","article-title":"The lifelong maintenance of mesencephalic dopaminergic neurons by Nurr1 and engrailed","volume":"21","author":"Alavian","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.expneurol.2020.113327_bb0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbr.2013.04.025","article-title":"Intracranial self-stimulation facilitates active-avoidance retention and induces expression of c-Fos and Nurr1 in rat brain memory systems","volume":"250","author":"Aldavert-Vera","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2020.113327_bb0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2007.01.069","article-title":"Regulation of fosB and DeltafosB mRNA expression: in vivo and in vitro studies","volume":"1143","author":"Alibhai","year":"2007","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.expneurol.2020.113327_bb0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","article-title":"Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson\u2019s disease","volume":"6","author":"Andersson","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2020.113327_bb0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","article-title":"Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson\u2019s disease","volume":"132","author":"Bastide","year":"2015","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.expneurol.2020.113327_bb0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jnc.13125","article-title":"Effects of the beta-adrenergic receptor antagonist propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian rat","volume":"134","author":"Bhide","year":"2015","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.expneurol.2020.113327_bb0040","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/jnr.21978","article-title":"Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats","volume":"87","author":"Bishop","year":"2009","journal-title":"J. Neurosci. Res."},{"issue":"16","key":"10.1016\/j.expneurol.2020.113327_bb0045","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1097\/00001756-199811160-00012","article-title":"Early assessment of motor dysfunctions aids in successful occlusion of the middle cerebral artery","volume":"9","author":"Borlongan","year":"1998","journal-title":"Neuroreport"},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2020.113327_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0006-8993(98)00663-5","article-title":"Genetic analysis of behavioral, neuroendocrine, and biochemical parameters in inbred rodents: initial studies in Lewis and Fischer 344 rats and in A\/J and C57BL\/6J mice","volume":"805","author":"Brodkin","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2020.113327_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fnins.2016.00013","article-title":"Fischer 344 and Lewis rat strains as a model of genetic vulnerability to drug addiction","volume":"10","author":"Cadoni","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113327_bb0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnmol.2013.00044","article-title":"Nur transcription factors in stress and addiction","volume":"6","author":"Campos-Melo","year":"2013","journal-title":"Front. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.expneurol.2020.113327_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013861","article-title":"Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats","volume":"5","author":"Cantuti-Castelvetri","year":"2010","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.expneurol.2020.113327_bb0070","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1523\/JNEUROSCI.0252-10.2010","article-title":"Striatal overexpression of DeltaFosB reproduces chronic levodopa-induced involuntary movements","volume":"30","author":"Cao","year":"2010","journal-title":"J. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.expneurol.2020.113327_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00726-001-0116-4","article-title":"Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"23","author":"Cenci","year":"2002","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/j.expneurol.2020.113327_bb0080","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.27337","article-title":"Animal models of l-dopa-induced dyskinesia in Parkinson\u2019s disease","volume":"33","author":"Cenci","year":"2018","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.expneurol.2020.113327_bb0085","first-page":"2694","article-title":"L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2020.113327_bb0090","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0306-4522(99)00294-8","article-title":"Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment","volume":"94","author":"Cenci","year":"1999","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.expneurol.2020.113327_bb0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cne.10261","article-title":"Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra","volume":"450","author":"Chu","year":"2002","journal-title":"J. Comp. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2020.113327_bb0100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/cne.20828","article-title":"Nurr1 in Parkinson\u2019s disease and related disorders","volume":"494","author":"Chu","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113327_bb0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.nbd.2015.03.005","article-title":"Interrogating the aged striatum: robust survival of grafted dopamine neurons in aging rats produces inferior behavioral recovery and evidence of impaired integration","volume":"77","author":"Collier","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.expneurol.2020.113327_bb0110","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1101\/lm.407706","article-title":"Knockdown of Nurr1 in the rat hippocampus: implications to spatial discrimination learning and memory","volume":"13","author":"Colon-Cesario","year":"2006","journal-title":"Learn. Mem."},{"issue":"Pt A","key":"10.1016\/j.expneurol.2020.113327_bb0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuropharm.2016.07.025","article-title":"Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats","volume":"110","author":"Conti","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2020.113327_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pneurobio.2016.07.002","article-title":"Expanding the repertoire of L-DOPA\u2019s actions: a comprehensive review of its functional neurochemistry","volume":"151","author":"De Deurwaerdere","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"11","key":"10.1016\/j.expneurol.2020.113327_bb0125","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrneurol.2013.209","article-title":"NURR1 in Parkinson disease--from pathogenesis to therapeutic potential","volume":"9","author":"Decressac","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2020.113327_bb0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbr.2003.10.009","article-title":"Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias","volume":"152","author":"Delfino","year":"2004","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.expneurol.2020.113327_bb0135","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/1531-8257(200005)15:3<459::AID-MDS1006>3.0.CO;2-3","article-title":"Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model","volume":"15","author":"Di Monte","year":"2000","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.expneurol.2020.113327_bb0140","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/cns.12536","article-title":"Nurr1-based therapies for Parkinson\u2019s disease","volume":"22","author":"Dong","year":"2016","journal-title":"CNS Neurosci. Ther."},{"issue":"2","key":"10.1016\/j.expneurol.2020.113327_bb0145","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.expneurol.2011.02.012","article-title":"Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats","volume":"229","author":"Dupre","year":"2011","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.expneurol.2020.113327_bb0150","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.biopsych.2014.07.007","article-title":"Selective inactivation of striatal FosB\/DeltaFosB-expressing neurons alleviates L-DOPA-induced dyskinesia","volume":"79","author":"Engeln","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.expneurol.2020.113327_bb0155","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neubiorev.2010.06.007","article-title":"Potential mechanisms underlying anxiety and depression in Parkinson\u2019s disease: consequences of l-DOPA treatment","volume":"35","author":"Eskow Jaunarajs","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.expneurol.2020.113327_bb0160","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biopsych.2014.07.019","article-title":"A role for mitogen- and stress-activated kinase 1 in L-DOPA-induced dyskinesia and FosB expression","volume":"79","author":"Feyder","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2020.113327_bb0165","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pnpbp.2017.02.024","article-title":"Lewis and Fischer 344 rats as a model for genetic differences in spatial learning and memory: cocaine effects","volume":"76","author":"Fole","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2020.113327_bb0170","first-page":"358176","article-title":"Corticostriatal plastic changes in experimental L-DOPA-induced dyskinesia","volume":"2012","author":"Ghiglieri","year":"2012","journal-title":"Parkinsons Dis."},{"issue":"7","key":"10.1016\/j.expneurol.2020.113327_bb0175","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/gt.2014.42","article-title":"Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways","volume":"21","author":"Gombash","year":"2014","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.expneurol.2020.113327_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120120","article-title":"A method for combining RNAscope in situ hybridization with immunohistochemistry in thick free-floating brain sections and primary neuronal cultures","volume":"10","author":"Grabinski","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2020.113327_bb0185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainres.2007.03.009","article-title":"Inbred Lewis and Fischer 344 rat strains differ not only in novelty- and amphetamine-induced behaviors, but also in dopamine transporter activity in vivo","volume":"1151","author":"Gulley","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2020.113327_bb0190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.expneurol.2016.01.018","article-title":"Exercise leads to the re-emergence of the cholinergic\/nestin neuronal phenotype within the medial septum\/diagonal band and subsequent rescue of both hippocampal ACh efflux and spatial behavior","volume":"278","author":"Hall","year":"2016","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2020.113327_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(95)01088-2","article-title":"Immunohistochemical studies of mesolimbic dopaminergic neurons in Fischer 344 and Lewis rats","volume":"706","author":"Harris","year":"1996","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.expneurol.2020.113327_bb0200","first-page":"511","article-title":"ADS-5102 (amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson\u2019s disease (EASE LID 2 study): interim results of an open-label safety study","volume":"7","author":"Hauser","year":"2017","journal-title":"J. Park. Dis."},{"issue":"10","key":"10.1016\/j.expneurol.2020.113327_bb0205","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1172\/JCI64145","article-title":"NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors","volume":"122","author":"Hawk","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.expneurol.2020.113327_bb0210","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0028-3908(81)90025-3","article-title":"Behavioural effects of central and peripheral injection of various analogues and metabolites of thyrotropin releasing hormone (TRH)","volume":"20","author":"Heal","year":"1981","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.expneurol.2020.113327_bb0215","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1073\/pnas.1401819111","article-title":"Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia","volume":"111","author":"Heiman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.expneurol.2020.113327_bb0220","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0896-6273(94)90061-2","article-title":"Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments","volume":"13","author":"Hope","year":"1994","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.expneurol.2020.113327_bb0225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson\u2019s disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.expneurol.2020.113327_bb0230","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/nbdi.2000.0372","article-title":"Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia","volume":"8","author":"Johansson","year":"2001","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.expneurol.2020.113327_bb0235","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1471-4159.1986.tb08506.x","article-title":"A semiautomated analysis method for catecholamines, indoleamines, and some prominent metabolites in microdissected regions of the nervous system: an isocratic HPLC technique employing coulometric detection and minimal sample preparation","volume":"46","author":"Kilpatrick","year":"1986","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.expneurol.2020.113327_bb0240","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2004.07.005","article-title":"Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia","volume":"17","author":"Konradi","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"Pt 8","key":"10.1016\/j.expneurol.2020.113327_bb0245","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease","volume":"136","author":"Kordower","year":"2013","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2020.113327_bb0250","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0006-8993(90)90049-H","article-title":"Systemic administration of thyrotropin-releasing hormone enhances striatal dopamine release in vivo","volume":"536","author":"Kreutz","year":"1990","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.expneurol.2020.113327_bb0255","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.celrep.2015.07.038","article-title":"BDNF reduces toxic Extrasynaptic NMDA receptor signaling via synaptic NMDA receptors and nuclear-calcium-induced transcription of inhba\/Activin a","volume":"12","author":"Lau","year":"2015","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.expneurol.2020.113327_bb0260","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jneumeth.2012.12.001","article-title":"Advances in thin tissue Golgi-cox impregnation: fast, reliable methods for multi-assay analyses in rodent and non-human primate brain","volume":"213","author":"Levine","year":"2013","journal-title":"J. Neurosci. Methods"},{"issue":"4","key":"10.1016\/j.expneurol.2020.113327_bb0265","first-page":"347","article-title":"Putaminal upregulation of FosB\/DeltaFosB-like immunoreactivity in Parkinson\u2019s disease patients with dyskinesia","volume":"1","author":"Lindgren","year":"2011","journal-title":"J. Park. Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2020.113327_bb0270","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","article-title":"A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function","volume":"16","author":"Lundblad","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.expneurol.2020.113327_bb0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nbd.2005.07.002","article-title":"Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats","volume":"21","author":"Maries","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.expneurol.2020.113327_bb0280","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/syn.20542","article-title":"Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult DBA\/2J mice: relationship with ventral striatum dopamine concentrations","volume":"62","author":"McNamara","year":"2008","journal-title":"Synapse"},{"issue":"13","key":"10.1016\/j.expneurol.2020.113327_bb0285","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00213-014-3854-1","article-title":"Amphetamine self-administration and dopamine function: assessment of gene x environment interactions in Lewis and Fischer 344 rats","volume":"232","author":"Meyer","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2020.113327_bb0290","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuroscience.2011.04.056","article-title":"Depotentiation of hippocampal long-term potentiation depends on genetic background and is modulated by cocaine self-administration","volume":"187","author":"Miguens","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2020.113327_bb0295","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.expneurol.2013.01.024","article-title":"Modeling dyskinesia in animal models of Parkinson disease","volume":"256","author":"Morin","year":"2014","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.expneurol.2020.113327_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2008.09.013","article-title":"Priming for l-dopa-induced dyskinesia in Parkinson\u2019s disease: a feature inherent to the treatment or the disease?","volume":"87","author":"Nadjar","year":"2009","journal-title":"Prog. Neurobiol."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2020.113327_bb0305","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0167-4943(05)80062-7","article-title":"Age-related changes in the metabolism of neurotransmitters and the effect of scavengers: an in vivo microdialysis study","volume":"19","author":"Nakano","year":"1994","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.expneurol.2020.113327_bb0310","first-page":"8(7)","article-title":"Activins and inhibins: roles in development, physiology, and disease","author":"Namwanje","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"20","key":"10.1016\/j.expneurol.2020.113327_bb0315","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1073\/pnas.191352698","article-title":"DeltaFosB: a sustained molecular switch for addiction","volume":"98","author":"Nestler","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.expneurol.2020.113327_bb0320","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0893-133X(95)00152-4","article-title":"Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress","volume":"14","author":"Ortiz","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2020.113327_bb0325","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2013.02.015","article-title":"Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB\/deltaFosB expression","volume":"541","author":"Padovan-Neto","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.expneurol.2020.113327_bb0330","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12640-018-9993-0","article-title":"Differential expression of striatal DeltaFosB mRNA and FosB mRNA after different levodopa treatment regimens in a rat model of Parkinson\u2019s disease","volume":"35","author":"Palafox-Sanchez","year":"2019","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.expneurol.2020.113327_bb0335","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopsych.2005.05.044","article-title":"ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice","volume":"59","author":"Pavon","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.expneurol.2020.113327_bb0340","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/nlme.1999.3952","article-title":"Hippocampal expression of the orphan nuclear receptor gene hzf-3\/nurr1 during spatial discrimination learning","volume":"74","author":"Pena de Ortiz","year":"2000","journal-title":"Neurobiol. Learn. Mem."},{"issue":"5","key":"10.1016\/j.expneurol.2020.113327_bb0345","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2020.113327_bb0350","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.neuro.2005.02.002","article-title":"Pathological synaptic plasticity in the striatum: implications for Parkinson\u2019s disease","volume":"26","author":"Picconi","year":"2005","journal-title":"Neurotoxicology"},{"issue":"4","key":"10.1016\/j.expneurol.2020.113327_bb0355","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/mds.20394","article-title":"Striatal synaptic plasticity: implications for motor learning and Parkinson\u2019s disease","volume":"20","author":"Pisani","year":"2005","journal-title":"Mov. Disord."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2020.113327_bb0360","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0006-8993(02)02724-5","article-title":"Effects of genetic background on neonatal Borna disease virus infection-induced neurodevelopmental damage. II. Neurochemical alterations and responses to pharmacological treatments","volume":"944","author":"Pletnikov","year":"2002","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.expneurol.2020.113327_bb0365","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0143-4179(91)90118-3","article-title":"The role of dopamine in regulation of thyrotropin-releasing hormone in the striatum and nucleus accumbens of the rat","volume":"19","author":"Przegalinski","year":"1991","journal-title":"Neuropeptides"},{"issue":"5","key":"10.1016\/j.expneurol.2020.113327_bb0370","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0143-4179(93)90044-B","article-title":"The role of dopamine receptors in the release of thyrotropin-releasing hormone from the rat striatum and nucleus accumbens: an in vitro study","volume":"25","author":"Przegalinski","year":"1993","journal-title":"Neuropeptides"},{"issue":"4","key":"10.1016\/j.expneurol.2020.113327_bb0375","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nurx.2006.08.001","article-title":"Behavioral tests for preclinical intervention assessment","volume":"3","author":"Schallert","year":"2006","journal-title":"NeuroRx"},{"issue":"5","key":"10.1016\/j.expneurol.2020.113327_bb0380","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.expneurol.2020.113327_bb0385","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40478-018-0653-7","article-title":"Regulation of dopamine neurotransmission from serotonergic neurons by ectopic expression of the dopamine D2 autoreceptor blocks levodopa-induced dyskinesia","volume":"7","author":"Sellnow","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"18","key":"10.1016\/j.expneurol.2020.113327_bb0390","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1523\/JNEUROSCI.2936-19.2020","article-title":"Striatal Nurr1 facilitates the dyskinetic state and exacerbates levodopa-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"40","author":"Sellnow","year":"2020","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.expneurol.2020.113327_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004574","article-title":"Dopamine signaling leads to loss of Polycomb repression and aberrant gene activation in experimental parkinsonism","volume":"10","author":"Sodersten","year":"2014","journal-title":"PLoS Genet."},{"issue":"12","key":"10.1016\/j.expneurol.2020.113327_bb0400","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/mds.10588","article-title":"Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats","volume":"18","author":"Steece-Collier","year":"2003","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.expneurol.2020.113327_bb0405","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cne.22037","article-title":"Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats","volume":"515","author":"Steece-Collier","year":"2009","journal-title":"J. Comp. Neurol."},{"issue":"5","key":"10.1016\/j.expneurol.2020.113327_bb0410","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/mds.27695","article-title":"Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia","volume":"34","author":"Steece-Collier","year":"2019","journal-title":"Mov. Disord."},{"issue":"15","key":"10.1016\/j.expneurol.2020.113327_bb0415","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1523\/JNEUROSCI.22-15-06790.2002","article-title":"Forced nonuse in unilateral parkinsonian rats exacerbates injury","volume":"22","author":"Tillerson","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113327_bb0420","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuropharm.2016.01.004","article-title":"Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration","volume":"105","author":"Valenza","year":"2016","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.expneurol.2020.113327_bb0425","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00259-017-3844-8","article-title":"Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson\u2019s disease","volume":"45","author":"Yoo","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"8","key":"10.1016\/j.expneurol.2020.113327_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000604","article-title":"Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity","volume":"5","author":"Zhang","year":"2009","journal-title":"PLoS Genet."},{"issue":"28","key":"10.1016\/j.expneurol.2020.113327_bb0435","doi-asserted-by":"crossref","first-page":"11655","DOI":"10.1523\/JNEUROSCI.0288-13.2013","article-title":"Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses","volume":"33","author":"Zhang","year":"2013","journal-title":"J. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620301588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620301588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:26:22Z","timestamp":1772843182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488620301588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":87,"alternative-id":["S0014488620301588"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113327","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113327"}}